Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lablytica Life Science AB
AB
Active
Org 5592179088
Virdings Allé 16, 754 50
Uppsala
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
11 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Lablytica Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
7M
14M
21M
28M
17M
2020
17M
2021
21M
2022
22M
2023
24M
2024
EBITDA
SEK millions
0M
1M
2M
3M
5M
2M
2020
2M
2021
4M
2022
4M
2023
3M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
17 062
16 979
21 444
22 395
24 263
Staff expenses
—
—
—
—
—
EBITDA
2 226
1 963
4 078
3 942
3 332
Depreciation & amort.
−49
−170
−311
−612
−1 050
EBIT
2 177
1 793
3 767
3 330
2 282
Net financials
−4
—
3
487
397
Profit before tax
814
2 033
2 607
2 524
36
Tax
−182
−426
−535
−542
−35
Net profit
632
1 607
2 072
1 982
1
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
11 107
13 881
17 309
17 578
15 725
Equity
3 256
4 863
6 935
8 917
8 918
Long-term debt
3 500
4 250
4 250
0
0
Short-term debt
3 991
3 649
3 842
5 085
3 405
Total debt
7 491
7 899
8 092
5 085
3 405
Financial ratios
5-year trend
EBITDA margin
13.7%
This company
15.8%
Market median
-13% vs market
2020
2024
Equity ratio
56.7%
This company
38.2%
Market median
+48% vs market
2020
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
2020
2024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Lablytica Life Science AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
